12:00 AM
 | 
Jun 09, 2014
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VOLT01: Phase III started

Voltarra and the University of Tasmania's Menzies Research Institute began a double-blind, placebo-controlled, Australian Phase III trial to evaluate VOLT01 in patients...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >